We present osprey 3.0, a new and greatly improved release of the osprey protein design software. osprey 3.0 features a convenient new Python interface, which greatly improves its ease of use. It is over two orders of magnitude faster than previous versions of osprey when running the same algorithms on the same hardware. Moreover, osprey 3.0 includes several new algorithms, which introduce substantial speedups as well as improved biophysical modeling. It also includes GPU support, which provides an additional speedup of over an order of magnitude. Like previous versions of osprey, osprey 3.0 offers a unique package of advantages over other design software, including provable design algorithms that account for continuous flexibility during design and model conformational entropy. Finally, we show here empirically that osprey 3.0 accurately predicts the effect of mutations on protein-protein binding. osprey 3.0 is available at http://www.cs.duke.edu/donaldlab/osprey.php as free and open-source software.
We present the third major release of the OSPREY protein design software, along with comparisons to experimental data that confirm its ability to optimize protein mutants for desired functions. osprey 3.0 has significant efficiency, ease-of-use, and algorithmic improvements over previous versions, including GPU acceleration and a new Python interface.
INTRODUCTION
For over a decade, the osprey software package 1,1-3 has offered the protein design community a unique combination of continuous flexibility modeling, ensemble modeling, and algorithms with provable guarantees 4, 5 . Having begun as a software release for the K * algorithm 2, 6 , which approximates binding constants using ensemble modeling, it now boasts a wide array of algorithms found in no other software. osprey has been used in many designs that were empirically successful-in vitro [6] [7] [8] [9] [10] [11] [12] and in vivo 7-10 as well as in non-human primates 7 . osprey's predictions have been validated by a wide range of experimental methods, including binding assays, enzyme kinetics and activity assays, in cell assays (MICs, fitness) and viral neutralization, in vivo studies, and crystal 7, 13 and NMR 9 structures.
However, as osprey grew to include more algorithms and features ( Fig. 1) , the code became increasingly complicated and difficult to maintain. The growing complexity of the software also hindered its ease-of-use. osprey 3.0 represents a complete refactoring of the code, and presents a simpler and more intuitive interface that makes protein redesign much easier than before. The new, developer-friendly code organization also facilitates adding new features to the free and open-source osprey project, both by ourselves and by other contributors. We have introduced a convenient Python scripting interface and added support for GPU acceleration of the bulk of the computation, allowing designs to be completed much more quickly and easily than in previous versions of osprey. We believe osprey 3.0 will be a very useful tool for both developers and users of provably accurate protein design algorithms.
Past successes of osprey osprey has been used for an impressive number of empirically successful designs, ranging from enzyme design to antibody design to prediction of antibiotic resistance mutations.
Notably, osprey has been successful in many prospective experimental studies, i.e., studies in which our designed sequences are tested experimentally, thus validating osprey through use in practice rather than simply through a retrospective comparison of osprey calculations to previous experimental results. osprey is most applicable to problems that can be posed in terms of biophysical state transitions like binding, allowing the K * algorithm and its variants to predict the optimal sequences based on an estimate of binding free energy computed using Boltzmann-weighted conformational ensembles. Moreover, most protein design problems can be posed in this way, sometimes in terms of binding to more than one ligand. osprey is capable of both positive design, in which binding of a designed protein to a target is increased, and negative design, in which binding to a target is decreased, as well as more complicated design objectives where specific binding to one target and not to another is required.
For example, we have successfully predicted novel resistance mutations to new inhibitors in MRSA (methicillin-resistant Staphylococcus aureus) using multistate design (combining negative and positive design). osprey does this by searching for sequences that have impaired drug binding compared to wild-type DHFR, but still form the enzyme-substrate complex as usual, allowing catalysis to proceed 10, 13 . Our predictions were validated not only biochemically and structurally, but also at an organismal level 13, 25, 26 . Similarly, we have successfully changed the preferred substrate of an enzyme-the phenylalanine adenylation domain of gramicidin S synthetase-from phenylalanine to leucine by modeling the two enzyme-substrate complexes, and searching for sequences with improved binding to leucine and reduced binding to phenylalanine 6 . The resulting designer enzymes exhibited improved catalysis, and designs changing the specificity from phenlyalanine to several charged amino acids were successful as well 6 . The combination of positive and negative design in osprey has also successfully designed mutants of the gp120 surface protein of HIV that bind specifically to particular classes of antibodies, enabling their use as probes for detecting and isolating those antibodies from human sera 12 .
These multistate design capabilities, long a mainstay of osprey, are accelerated by the modules BBK * (described below) and COMETS (described in Ref. 21) . COMETS provably returns the sequence that minimizes any desired linear combination of the energies of multiple protein states, subject to constraints on other linear combinations. Thus, COMETS can target nearly any combination of affinity (to one or multiple ligands), specificity, and stability (for multiple states if needed). COMETS and BBK * have been integrated into osprey 3.0 and accelerated, and they are currently the only provable multi-state design algorithms that run in time sublinear in the size M of the sequence space. This can be important, since M is exponential in the number of simultaneously mutable residue positions.
Further successes of osprey have involved improving positive design, e.g., the interaction of the anti-HIV antibody VRC07 with its antigen, gp120. Using this approach, we collaborated with the NIH Vaccine Research Center to design a broadly neutralizing antibody (VRC07-523LS) against HIV with unprecedented breadth and potency that is now in clinical trials (Clinical Trial Identifier: NCT03015181 7, 27 ). We also have designed allosteric inhibitors of the leukemia-associated protein-protein interaction between Runx1 and CBFβ 9 .
Similarly, we have used osprey to develop peptide inhibitors of CAL, a protein involved in cystic fibrosis 8 . The CBFβ and CAL inhibitors were successful in vitro and in vivo 8,9 . In addition, a number of other research groups have successfully used the osprey algorithms and software (by themselves) to perform biomedically important protein designs, e.g., to design anti-HIV antibodies that are easier to induce 28 ; to design a soluble prefusion closed HIV-1-Env trimer with reduced CD4 affinity and improved immunogenicity 29 ; to design a transmembrane Zn 2+ -transporting four-helix bundle 30 ; to optimize stability and immunogenicity of therapeutic proteins [31] [32] [33] ; and to design sequence diversity in a virus panel and predict the epitope specificities of antibody responses to HIV-1 infection 34 .
We believe osprey 3.0 will enable an even greater range of successful designs.
PERFORMANCE ENHANCEMENTS IN osprey 3.0
Engineering improvements yield large single-threaded speedups osprey 3.0's code has been heavily optimized to improve single-threaded performance relative to the previous version, osprey 2.2 21 . Two main areas have received the most attention and the most improvement in performance so far: A * search speed, and conformation minimization speed.
osprey uses the A * search algorithm 15 to perform its combinatorial search over sequence and conformational space 2, 16, 19 . The performance of A * search in osprey depends mostly on the size of the conformation space of the design: the time required for search scales strongly with the number of mutable and flexible residues. Search time is also dependent on the speed at which we can evaluate the energy scoring functions on A * nodes. Optimizations in osprey 3.0 have dramatically increased the A * node scoring speed, mainly by caching the results of expensive computations and reusing them at different nodes. Many intermediate values used by the A * scoring functions need only be computed once per design. This reduces the cost of node scoring by roughly an order of magnitude. We can also score child nodes differentially against their parent nodes to speed up node scoring. Caching intermediate values during the parent node scoring and using them to simplify child node scoring yields roughly another order of magnitude speedup in A * node scoring. osprey 3.0 also includes optimizations to improve the performance of forcefield evaluation and conformation minimization. Conformation minimization is typically the bottleneck in osprey calculations with continuous flexibility 2, 16, 19, 20 . The code in osprey 3.0 that evaluates forcefield energies for a protein conformation has been heavily optimized, although speed gains here over osprey 2 are modest (roughly two-fold), since the original code was already well-optimized in this area. Much larger performance increases were gained by caching forcefield parameters and lists of atom pairs between different conformations to be minimized, which yielded roughly a 10-fold increase in speed. osprey 3.0 also increases performance by only evaluating forcefield terms involving mutable and/or flexible residues in a design, since interaction energies between other residues will be identical across all sequences and conformations. Since most designs only model a minority of the residues in a protein as flexible, this can be a substantial improvement.
Performance comparisons are shown for 45 protein design test cases in Fig. 2 and Table 1. All these test cases model continuous protein flexibility 2, 16, 17 , and 18 of them involve provably accurate partition function calculations (see Table 1 and Ref. 17 for details). To summarize, the optimizations to single-threaded performance described above made osprey 
GPU acceleration reduces design runtimes
One of the key challenges in protein design is modeling and searching the many continuous conformational degrees of freedom inherent in proteins and other molecules. The sidechain conformations of each amino-acid type are generally found in clusters, known as rotamers 35 , so it is common practice to approximate protein conformational space as discrete by forcing each residue to be in the modal conformation of one of these clusters 14, 15 . However, design accuracy is increased significantly when continuous flexibility is taken into account, by allowing the continuous degrees of freedom to move within finite bounds around these modal values 1, 16, 19, 36 . Moreover, this increase in accuracy depends on considering continuous flexibility during the conformational search process, rather than simply performing minimization post hoc on the top-scoring sequences and conformations output by a discrete search algorithm. Although such a post hoc minimization approach would obtain more energetically favorable models of the top sequences, it would still produce the same top sequences as a purely discrete design would, which have been shown to not be truly the top sequences, even if a much finer discrete rotamer subsampling is allowed 1, 16 . For example, clashing discrete rotamers can often be converted to favorable conformations by relatively small adjustments in the sidechain conformations 2, 16, 19, 20 . As a result, designs performed with continuous flexibility taken into account throughout the search yield significantly different, and more biologically accurate, sequences than the same designs performed using discrete search 1, 16, 19 .
To address this problem, osprey includes several algorithms to design proteins while taking continuous flexibility into account throughout the process of sequence and conformational search 2,16-20 . These algorithms predict optimal protein sequences with provable guarantees of accuracy given a biophysical model that includes continuous flexibility.
This minimization-aware design approach requires energy minimization to be performed for a large number of conformations (within the bounds on the continuous degree of freedom that define each conformation). This minimization is a relatively expensive operation, so the bulk of a design's runtime can be spent on energy minimization of conformations. Therefore, improvements to the speed of energy minimization can have a dramatic impact on osprey runtimes.
Much work has been done to optimize osprey for execution on CPUs, particularly highly multi-core CPUs and even networked clusters of CPU-powered servers 37, 38 . However, modern GPU hardware enables high-performance computation for some specific tasks at a fraction of the cost of large CPU clusters, mainly due to the huge video game industry, which propels innovation in hardware design and drives down costs. The widespread adoption of fast and highly programmable GPUs in the past decade has transformed many areas of computational science, including quantum chemistry 39 , computer vision 40 , and cryptography 41 . In particular, GPUs have been found to produce speedups of approximately an order of magnitude in molecular dynamics simulations [42] [43] [44] , which, like osprey, must sum huge numbers of forcefield energy terms and can use the GPU to parallelize this computation. GPUs have also been used to accelerate the A * search step of protein design 45 , albeit without addressing the continuous minimization bottleneck.
Thus, in order to bring the benefit of GPUs to continuously flexible protein design calculations, osprey 3.0 includes GPU programs (called kernels) built using the CUDA framework 46 that implement the forcefield calculations and local minimization algorithms used in protein redesign.
We present performance results of these GPU kernels on various hardware platforms in minimizations with few atom pairs. Future versions of these GPU kernels will likely offer significantly higher performance on the same hardware -perhaps allowing minimization speeds many times faster than today's GPU kernels. This in turn will make it even more efficient to perform minimization-aware protein design, and allow minimization-aware designs with even more mutable and flexible residues and with more mutation options per residue.
PYTHON SCRIPTING IMPROVES EASE-OF-USE
One of the most visible additions to osprey 3.0 is the Python application programming interface (API), which allows fine-grained control over design parameters in a streamlined and easy-to-use experience. osprey 3.0 still supports a command-line interface with configuration files for backwards compatibility, but new development will be focused mostly on the new Python interface.
The osprey 3.0 distribution contains a Python module which is installed using the popular package manager pip. Once installed, using osprey 3.0 is as easy as writing a Python script. High-performance computations are still performed in the Java virtual machine to give the fastest runtimes, so Java is still required to run osprey 3.0, but communication between the Python environment and the Java environment is handled behind-the-scenes, and osprey 3.0 still looks and feels like a regular Python application.
See Figure 4 for a complete example of a Python script that performs a very simple design using osprey 3.0, and Figure 5 for a slightly more involved design using BBK * 36 (a new algorithm in osprey 3.0, described in its own section below). Figure 6 20, we have shown that backbone flexibility as modeled by CATS is sometimes critical for avoiding nonphysical steric clashes (Fig. 7B,C) and often affects energetics significantly. For example, mutating residue 54 of the antibody VRC07 to tryptophan improves its binding to its antigen (HIV surface protein gp120) 7 , but a design to recapitulate this mutation found it to be blocked by a steric clash unless CATS was used to find a backbone motion that escapes the clash 20 . In this design, CATS significantly outperformed a provable search over backrub 53 motions, which are also available in osprey 19, 54 .
CATS is intended to be run as part of the flexibility model for osprey's other algorithms, yielding efficient calculations with continuous flexibility in both the sidechains and the backbone. osprey's convenient interface allows a user to add CATS flexibility to a design merely by specifying the start and end points of the backbone segment to be made flexible.
BBK * : Efficiently computing the tightest binding sequences from a combinatorially large number of binding partners
In previous versions of osprey, the K * algorithm 24 modeled an ensemble of Boltzmannweighted conformations to approximate the thermodynamic partition function. It combined minimized dead-end elimination pruning 14 with A * 14,55 gap-free conformation enumeration to compute provable ε-approximations to the partition functions for the protein and ligand states of interest. K * combined these partition function scores to approximate the association constant, K a , as the ratio of ε-approximate partition functions between the bound and unbound states of a protein-ligand complex. Notably, each partition function ratio, called a K * score, is provably accurate with respect to the biophysical input model 2, 16, 24 .
Although K * efficiently and provably approximated K a for a given sequence, it had to compute a K * score for each sequence of interest. All provable ensemble-based algorithms prior to BBK * , as well as many heuristic algorithms that optimize binding affinity, are single-sequence algorithms which must compute the binding affinity for each possible sequence. The number of sequences, of course, is exponential in the number of simultaneously mutable residue positions. Therefore, designs with many mutable residues rapidly became intractable. osprey 3.0 provides a new algorithm, BBK * , which overcomes this challenge. Importantly, BBK * also contains many other powerful algorithmic improvements and implementation optimizations: the parallel architecture of BBK * , which enables concurrent energy minimization, and a novel two-pass partition function bound, which minimizes far fewer conformations while still computing a provable ε-approximation to the partition function. Combined with the combinatorial pruning power of the MS bound, BBK * is able to search over much larger sequence spaces than previously possible with single-sequence K * (Fig. 8 ). In computational experiments on 204 protein design problems, BBK * accurately predicted the tightest-binding sequences while only computing K * scores for as few as one in 10 5 of the sequences in the search space 36 . Moreover, in computational experiments on 51 protein-ligand design problems, BBK * was up to 1982-fold faster than single-sequence K * , despite provably producing the same results 36 .
These improvements show that BBK * not only accelerates protein designs that were possible with previous provable algorithms, it also efficiently performs designs that are too large for previous methods. Because energy decreases as a function of distance, many protein design algorithms model protein energetics with energy functions which omit pairwise interactions between sufficiently distant residues. These sparse energy functions not only provide a simpler, more efficiently computed model of energy, but also induce optimal substructure to the problem: because not all residues interact, the optimal conformation for a given residue can be independent of the conformations at other residues. BWM * exploits this optimal substructure by 1) representing the sparse interactions with a sparse residue interaction graph, and 2) computing a branchdecomposition for use in dynamic programming. BWM * , unlike treewidth-based methods that also exploit the sparsity of pairwise residue interactions to efficiently compute the GMEC 56 , enumerates a gap-free list of conformations in order of increasing sparse energy. Because this list is gap-free, BWM * not only computes the GMEC of the sparse energy function, but also recovers the GMEC of the full energy function, as shown in Ref. 23 . By enumerating all conformations within the provable sparse energy bound between the sparse and full GMEC, BWM * computes a list of conformations that is guaranteed to contain the full GMEC, as well as the sparse GMEC 57 . Moreover, because BWM * can enumerate conformations in gap-free order up to any energy threshold specified by the user, it can be used to accurately compute partition functions, and thus binding free energies that account correctly for entropy, using the K * algorithm 2,24 .
Thus, in practice, BWM * circumvents the worst-case complexity of traditional methods such as A * for designs with sparse energy functions, computing the sparse GMEC of an n-residue design with at most q rotamers per residue in O(nw 2 q 3 2 w ) time, and also enumerates each additional conformation in merely O(n log q) time, which is up to three orders of magnitude faster than traditional A * in practice 23 .
ACCURACY BENCHMARKS
We first tested the accuracy of osprey 3.0 for the subset of algorithms also available in osprey 2.2β, by running both versions of osprey on the same test cases and checking that the results matched. Since the accuracy of osprey 2.2β using these algorithms has been experimentally confirmed (see Introduction), by transitivity, our tests confirmed osprey 3.0's accuracy. In addition, we performed new, retrospective tests, described below.
To evaluate the accuracy of the implementation of the newest optimizations in osprey 3.0, we performed a series of designs for a variety of protein-protein interfaces (PPIs) as retrospective validation. We used K * 24 to computationally predict experimentally measured changes in binding for each PPI. Each protein structure is listed by name and PDB ID in Table 2 [58] [59] [60] [61] . These systems include barnase with its peptide inhibitor barstar 62,63 , the cytochrome c:cytochrome c peroxidase complex 64 , interferon α-2 (IFNα2) in complex with interferon α/β receptor 2 (IFNAR2) 65 , and the interleukin 2 (IL-2):IL-2 receptor α (IL-2Rα) complex 66 .
Our retrospective validation experiments focused on mutations at residues in or proximal to the protein-protein interface that were not limited to alanine scanning. Including some of these tested and reported mutations [62] [63] [64] [65] [66] , for each structure we tested anywhere from 5 to 19 designs. In total, we tested 58 mutations using default, out-of-the-box osprey 3.0 settings and parameters. Each design included one or two mutable residues along with a set of surrounding flexible residues (See Table 2 ). Flexible residues were chosen by selecting all residues within 4Å of the mutable residues and removing those that only have backbone interactions. Two example designs are shown in Figure 9 , where osprey 3.0 and K * accurately predict the effect of two point mutations in the interface of the IFNα2:IFNAR2 complex (highlighted in blue in Table 2 ).
For each system, the K * scores were ranked in increasing order of reported experimental binding. Spearman's ρ values were subsequently calculated for each system by calculating the statistical dependence between the K * score rankings and the experimentally measured rankings (See Table 2 and Figure 10 ). This is a sound measure because generally the output of a design calculation that is used to decide which mutants to make experimentally is simply the intra-system ranks of the mutants. Looking at the values in Table 2 , we see a high correlation in the rankings between experimentally measured binding and binding predicted by osprey 3.0 and K * for each system with values ranging from 0.500 to 0.795.
We found that, across the tested systems, the Spearman's ρ value is 0.762. This value is the Pearson correlation of the intra-system ranks of all the mutants. Overall, these correlations are very good for design for affinity in computational protein design.
DISCUSSION
osprey has demonstrated its accuracy and utility in practice through many prospective designs that have performed well experimentally [6] [7] [8] [9] [10] [11] [12] . osprey 3.0 is at least as accurate as the versions of osprey used to perform these designs, because it uses the same biophysical model used in those studies, with provable guarantees of accuracy given the biophysical model. We have compared design results using osprey 2.2 and osprey 3.0 to confirm agreement. However, osprey 3.0 performs such designs much more efficiently, due to the engineering improvements described here. Moreover, in this paper we have performed additional comparisons to experimental data to confirm the accuracy of osprey 3.0. osprey 3.0 also includes methods to improve the biophysical model and thus improve accuracy still further (should the user choose to select osprey's newer models).
As our benchmark results here show, we have made substantial progress toward correctly predicting the effect of mutations on protein activity. The high accuracy comes from osprey's accurate biophysical model, which accounts for both continuous protein flexibility and conformational entropy, together with algorithms that provably return optimal sequences given that model. In fact, no other software can provide a provable guarantee of accuracy given a model that accounts for continuous flexibility and conformational entropy. Moreover, osprey's combinatorial algorithms 4,5 compute optimal sequences efficiently even when searching over a large sequence space.
The large speedups in osprey 3.0, together with the easy-to-use Python interface, thus make it much more tractable to perform protein design with such biophysically realistic modeling and with guaranteed accuracy given the model. In particular, osprey 3.0 benefits from many sources of speedups that can be used together. Speedups from osprey 3.0's optimization of the conformational minimization, forcefield evaluation, and A* routines can exceed two orders of magnitude even compared to osprey 2.2 21 running on the same CPU hardware. Together with an additional speedup of over an order of magnitude from GPU's, a design that would take months using osprey 2.2 could easily take only a few hours using osprey 3.0. Many designs could see even greater speedups, because in addition to these engineering improvements, some of the algorithmic improvements in osprey 3.0 provide a dramatic increase in computational efficiency.
The improvements in modeling facilitated by osprey 3.0's new algorithms also make protein design with osprey more realistic. However, there is still much room for improvement in the biophysical model used by osprey, and indeed by all currently available protein design software. Modeling of larger backbone motions, more realistic interactions with water, and electronic polarization, among other phenomena, are all likely to yield substantial improvements in accuracy. The refactored architecture of osprey 3.0 will make it easier to experiment with algorithms that facilitate these modeling improvements, and to implement these algorithms within osprey's current code base. Moreover, we have released osprey Boltzmann-weighted thermodynamic conformational ensembles. In osprey 3.0 we introduced software improvements that will make these algorithms much more practical for the wider design community: performance that is orders of magnitude faster, and a Python interface that makes osprey much easier to use. In addition, we expanded the range of biophysical modeling assumptions that osprey can accommodate, both in terms of molecular flexibility and energy functions. As with previous versions, we are releasing osprey 3.0 as free and open-source software to maximize its benefit to the community. We hope this new version will be of significant utility to designers, whether they have used osprey before or are trying it for the first time. According to the allowed flexibility, OSPREY runs a specific pruning algorithm followed by a highly optimized descendant of the A * search algorithm 22 . The A * output generates a ranking based on either the lowest-energy structure of each sequence, or an ensemble of structures computed by the K * algorithm. (F) The BWM * 23 algorithm exploits sparse residue interaction graphs and branch decomposition to outperform traditional A * . (G) The K * 2,24 algorithm calculates a K * score (an approximation of the binding constant, K a ) by provably estimating the partition function for the protein, the ligand, and the protein-ligand complex. The K * algorithm exploits a thermodynamic ensemble of structures as opposed to a single structure, as illustrated in the panel (PDB ID: 3FQC). K * can also be used to find sequences that have a high affinity for one ligand (positive design) while having a low affinity for another (negative design) by taking a ratio of K * scores 10,13 . Table 1 ), shown on a log scale. Designs that only finished with osprey 3.0 (given a 17-day time limit) are shown on the right in red. All test cases involve continuous flexibility 2,16 and minimization-aware DEE 16, 17 ; 18 involve provably accurate partition function calculations (see Table 1 and Ref. 17 for details). This design produces a peptide to bind human fibronectin (the "ligand strand," i.e. chain A) by optimizing a fragment of the protein FnBPA from Staphylococcus aureus (the "protein strand," chain G), which has been crystallized in complex with fibronectin domains (PDB ID: 2RL0 50 ). As in Fig. 4 , the script defines the starting crystal structure, mutable residues, and level of mutability and flexibility (here including continuous flexibility) in the form of Python strand objects. Fig. 6 represents this design graphically. This design is accelerated by parallelism, running on 4 CPU cores. This example thus shows it is easy to invoke and use parallelism within the osprey 3.0 software. compared to (F), but these are not visually obvious, thus emphasizing the importance of K * , which successfully picks up these nuanced changes and correctly predicts improved binding (See Table 2 ). (G) and (I) show the top 10 conformations in the conformational ensemble used in the K * calculation for each sequence. Not shown are the ensembles for the unbound states that are also used to calculate the K * scores. Table 2 ). Each system is represented by its corresponding PDB ID and a linear trendline is shown for each in its corresponding color according to the legend. 
